Nemes Rush Group’s Medtronic MDT Stock Holding History

Nemes Rush Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$530K	Buy	6,118 +30	+0.5%	+$2.87K	0.05%	135
2025 Q4	$585K	Sell	6,088 -26	-0.4%	-$2.53K	0.06%	125
2025 Q3	$582K	Sell	6,114 -84	-1%	-$7.72K	0.06%	120
2025 Q2	$540K	Sell	6,198 -123	-2%	-$10.4K	0.06%	125
2025 Q1	$568K	Sell	6,321 -867	-12%	-$77.6K	0.07%	116
2024 Q4	$574K	Sell	7,188 -5,190	-42%	-$449K	0.07%	119
2024 Q3	$1.08M	Buy	12,378 +3,019	+32%	+$254K	0.16%	84
2024 Q2	$737K	Sell	9,359 -3,780	-29%	-$310K	0.1%	98
2024 Q1	$1.15M	Sell	13,139 -116,862	-90%	-$9.97M	0.16%	82
2023 Q4	$10.7M	Buy	130,001 +1,274	+1%	+$97.1K	1.73%	18
2023 Q3	$10.1M	Buy	128,727 +6,516	+5%	+$545K	1.83%	17
2023 Q2	$10.8M	Buy	+122,211	New	+$10.5M	1.9%	13

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nemes Rush Group's MDT Position: Q1 2026 in Review

Nemes Rush Group increased its Medtronic (MDT) stake by 0.49% in Q1 2026, buying an estimated $2.87K and bringing the position to 6,118 shares worth $530K. The position accounts for 0.05% of the portfolio, ranked #135.

Nemes Rush Group first reported a position in MDT in Q2 2023 and has held it in 12 quarters since. The position peaked at $10.8M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Nemes Rush Group held 6,118 shares of Medtronic worth $530K as of Q1 2026.
Nemes Rush Group bought 30 Medtronic shares in Q1 2026, an estimated $2.87K.
Medtronic made up 0.05% of Nemes Rush Group's portfolio in Q1 2026, its #135 holding.
Nemes Rush Group first reported a position in Medtronic in Q2 2023 and has held it in 12 quarters since.
Nemes Rush Group's Medtronic position peaked at $10.8M in Q2 2023.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.